$5.24 Billion is the total value of Perceptive Advisors's 278 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 52.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $587,258,000 | +256.8% | 9,583,178 | +167.9% | 11.21% | +35.4% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $539,520,000 | +209.8% | 35,777,194 | +106.8% | 10.30% | +17.5% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS | $420,334,000 | +187.5% | 3,577,604 | +95.2% | 8.02% | +9.1% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $264,798,000 | +146.1% | 8,528,132 | +116.8% | 5.06% | -6.6% |
| ZGNX | Buy | ZOGENIX INC | $257,292,000 | +414.6% | 7,340,714 | +112.9% | 4.91% | +95.2% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $221,254,000 | +245.2% | 1,847,640 | +152.0% | 4.22% | +31.0% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $150,042,000 | +133.7% | 4,314,022 | +100.0% | 2.86% | -11.3% |
| RTRX | Buy | RETROPHIN INC | $133,718,000 | +158.1% | 5,372,408 | +101.0% | 2.55% | -2.1% |
| AVXS | Buy | AVEXIS INC | $129,846,000 | +482.8% | 1,342,362 | +395.0% | 2.48% | +121.1% |
| CORI | Buy | CORIUM INTL INC | $129,572,000 | +197.0% | 11,694,266 | +100.0% | 2.47% | +12.7% |
| XLRN | Buy | ACCELERON PHARMA INC | $120,638,000 | +458.1% | 3,232,518 | +354.5% | 2.30% | +111.7% |
| TSRO | Buy | TESARO INC | $100,350,000 | +99.6% | 777,302 | +116.2% | 1.92% | -24.3% |
| RGNX | Buy | REGENXBIO INC | $94,974,000 | +250.7% | 2,882,372 | +110.2% | 1.81% | +33.0% |
| DOVA | Buy | DOVA PHARMACEUTICALS INC | $85,174,000 | +123.9% | 3,508,030 | +105.6% | 1.63% | -15.0% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $73,254,000 | +128.4% | 9,452,228 | +116.6% | 1.40% | -13.3% |
| NXTM | Buy | NXSTAGE MEDICAL INC | $69,802,000 | +79.0% | 2,529,046 | +62.6% | 1.33% | -32.1% |
| ANAB | Buy | ANAPTYSBIO INC | $68,660,000 | +201.3% | 1,964,538 | +106.3% | 1.31% | +14.3% |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $64,124,000 | +305.6% | 3,260,000 | +196.4% | 1.22% | +54.0% |
| XNCR | Buy | XENCOR INC | $59,276,000 | +117.2% | 2,586,190 | +100.0% | 1.13% | -17.6% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $59,172,000 | +162.6% | 849,322 | +91.0% | 1.13% | -0.4% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $52,702,000 | +172.3% | 50,390 | +143.5% | 1.01% | +3.3% |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $50,526,000 | +134.5% | 2,780,762 | +100.0% | 0.96% | -11.0% |
| VBIV | Buy | VBI VACCINES INC | $50,556,000 | +77.0% | 13,131,686 | +100.0% | 0.96% | -32.8% |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $48,926,000 | +131.5% | 1,152,838 | +94.8% | 0.93% | -12.1% |
| HUM | Buy | HUMANA INC | $48,726,000 | +159.3% | 200,000 | +156.1% | 0.93% | -1.7% |
| MYOK | Buy | MYOKARDIA INC | $47,196,000 | +225.7% | 1,101,434 | +99.1% | 0.90% | +23.6% |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $44,430,000 | +231.1% | 6,170,916 | +113.9% | 0.85% | +25.6% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $43,770,000 | +223.4% | 1,562,618 | +120.9% | 0.84% | +22.8% |
| SELB | Buy | SELECTA BIOSCIENCES INC | $42,424,000 | +167.9% | 2,324,650 | +191.6% | 0.81% | +1.6% |
| GLPG | Buy | GALAPAGOS N Vspon adr | $42,004,000 | +142.4% | 412,810 | +82.3% | 0.80% | -8.0% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $38,670,000 | +221.7% | 745,342 | +163.5% | 0.74% | +22.0% |
| CBAY | New | CYMABAY THERAPEUTICS INC | $37,896,000 | – | 4,701,764 | +100.0% | 0.72% | – |
| QTNT | Buy | QUOTIENT TECHNOLOGY INC | $36,748,000 | +41.3% | 7,453,972 | +100.7% | 0.70% | -46.4% |
| ALBO | Buy | ALBIREO PHARMA INC | $35,406,000 | +103.4% | 1,690,000 | +100.0% | 0.68% | -22.8% |
| NVTA | Buy | INVITAE CORP | $35,314,000 | +468.8% | 3,769,000 | +480.3% | 0.67% | +116.0% |
| KDMN | Buy | KADMON HLDGS INC | $34,744,000 | +72.2% | 10,371,694 | +100.0% | 0.66% | -34.7% |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $32,530,000 | +106.4% | 3,098,010 | +116.8% | 0.62% | -21.7% |
| ONCE | New | SPARK THERAPEUTICS INC | $32,098,000 | – | 360,000 | +100.0% | 0.61% | – |
| ABEOW | Buy | ABEONA THERAPEUTICS INC*w exp 12/24/201 | $31,692,000 | +639.6% | 2,519,272 | +100.0% | 0.60% | +180.1% |
| ALQA | Buy | ALLIQUA BIOMEDICAL INC | $30,916,000 | +1874.2% | 8,467,902 | +100.0% | 0.59% | +646.8% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $30,858,000 | +238.2% | 883,666 | +100.0% | 0.59% | +28.3% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $30,260,000 | +11.1% | 1,700,000 | +58.2% | 0.58% | -57.8% |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $29,334,000 | – | 1,858,920 | +100.0% | 0.56% | – |
| ATRS | Buy | ANTARES PHARMA INC | $28,214,000 | +105.3% | 8,707,794 | +104.1% | 0.54% | -22.0% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $27,960,000 | +126.8% | 1,285,596 | +94.0% | 0.53% | -13.9% |
| TFX | New | TELEFLEX INC | $26,714,000 | – | 110,400 | +100.0% | 0.51% | – |
| SYBX | New | SYNLOGIC INC | $26,100,000 | – | 1,372,704 | +100.0% | 0.50% | – |
| AVEO | Buy | AVEO PHARMACEUTICALS INC | $25,110,000 | +88.2% | 6,830,232 | +13.6% | 0.48% | -28.6% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $22,886,000 | +662.9% | 612,268 | +410.2% | 0.44% | +189.4% |
| ARGX | Buy | ARGENX SEsponsored adr | $20,196,000 | +111.6% | 900,000 | +100.0% | 0.39% | -19.6% |
| QURE | Buy | UNIQURE NV | $19,970,000 | +195.9% | 2,080,238 | +90.8% | 0.38% | +12.1% |
| ARDX | Buy | ARDELYX INC | $17,712,000 | +91.8% | 19,457,672 | +974.7% | 0.34% | -27.3% |
| ABMD | New | ABIOMED INC | $17,444,000 | – | 103,458 | +100.0% | 0.33% | – |
| ATHN | New | ATHENAHEALTH SHARES | $17,410,000 | – | 140,000 | +100.0% | 0.33% | – |
| MRNS | New | MARINUS PHARMACEUTICALS | $17,054,000 | – | 2,905,400 | +100.0% | 0.33% | – |
| URGN | Buy | UROGEN PHARMA LTD | $16,958,000 | +249.1% | 538,028 | +100.0% | 0.32% | +32.8% |
| Buy | ANI PHARMACEUTICALSnote 3.00% 12/0 | $16,238,000 | +105.3% | 15,000,000 | +100.0% | 0.31% | -22.1% | |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $15,636,000 | +2010.1% | 930,712 | +2010.2% | 0.30% | +708.1% |
| CSU | Buy | CAPITAL SR LIVING CORP | $14,062,000 | +74.4% | 1,120,346 | +111.3% | 0.27% | -34.0% |
| EXAS | Buy | EXACT SCIENCES CORP | $12,764,000 | +260.9% | 270,888 | +170.9% | 0.24% | +37.1% |
| CMTA | New | CLEMENTIA PHARMACEUTICALS IN | $12,582,000 | – | 704,500 | +100.0% | 0.24% | – |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $12,402,000 | +139.2% | 2,234,648 | +100.0% | 0.24% | -9.2% |
| ZYME | Buy | ZYMEWORKS INC | $11,664,000 | +91.2% | 1,461,536 | +100.0% | 0.22% | -27.4% |
| SRRA | Buy | SIERRA ONCOLOGY INC | $11,332,000 | +165.0% | 7,310,372 | +100.0% | 0.22% | +0.5% |
| HRTX | New | HERON THERAPEUTICS INC | $10,658,000 | – | 660,000 | +100.0% | 0.20% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $10,448,000 | – | 180,000 | +100.0% | 0.20% | – |
| CLSD | Buy | CLEARSIDE BIOMEDICAL INC | $10,294,000 | +82.2% | 1,240,362 | +100.0% | 0.20% | -30.6% |
| ZLAB | New | ZAI LAB LTDadr | $9,450,000 | – | 350,000 | +100.0% | 0.18% | – |
| OMED | New | ONCOMED PHARMACEUTICALS INC | $9,386,000 | – | 2,076,578 | +100.0% | 0.18% | – |
| NLNK | New | NEWLINK GENETICS CORP | $9,162,000 | – | 900,000 | +100.0% | 0.18% | – |
| MTEM | New | MOLECULAR TEMPLATES INC | $8,462,000 | – | 1,448,266 | +100.0% | 0.16% | – |
| MMSI | New | MERIT MEDICAL SYS INC | $8,470,000 | – | 200,000 | +100.0% | 0.16% | – |
| NEPT | Buy | NEPTUNE TECHNOLOGIES BIORESO | $8,226,000 | +116.4% | 13,039,268 | +100.0% | 0.16% | -17.8% |
| IVC | New | INVACARE CORP | $7,900,000 | – | 400,000 | +100.0% | 0.15% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $7,462,000 | – | 73,526 | +100.0% | 0.14% | – |
| NCNA | New | NUCANA PLSsponsored adr | $7,348,000 | – | 400,000 | +100.0% | 0.14% | – |
| HSGX | Buy | HISTOGENICS CORP | $7,038,000 | +121.2% | 3,555,554 | +100.0% | 0.13% | -16.2% |
| RGEN | New | REPLIGEN INC | $6,698,000 | – | 174,800 | +100.0% | 0.13% | – |
| GILD | New | GILEAD SCIENCES INC | $6,482,000 | – | 80,000 | +100.0% | 0.12% | – |
| VRNA | Buy | VERONA PHARMA PLCsponsored adr | $6,140,000 | +163.4% | 400,000 | +100.0% | 0.12% | 0.0% |
| DBVT | New | DBV TECHNOLOGIES S Aput | $5,616,000 | – | 1,100,000 | +100.0% | 0.11% | – |
| PFNX | Buy | PFENEX INC | $5,110,000 | +50.6% | 1,691,946 | +100.0% | 0.10% | -42.7% |
| VIVE | Buy | VIVEVE MEDICAL INC | $5,102,000 | -20.2% | 973,976 | +9.4% | 0.10% | -69.9% |
| OCRX | Buy | OCERA THERAPEUTICS INC | $4,648,000 | +96.5% | 4,077,760 | +100.0% | 0.09% | -25.2% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCcall | $4,630,000 | – | 200,000 | +100.0% | 0.09% | – |
| MGCD | Buy | MGC DIAGNOSTICS CORP | $4,522,000 | +111.3% | 504,654 | +100.0% | 0.09% | -20.4% |
| ADMA | Buy | ADMA BIOLOGICS INC | $4,442,000 | +60.4% | 1,442,204 | +100.0% | 0.08% | -38.8% |
| MCRB | New | SERES THERAPEUTICS INC | $4,330,000 | – | 270,000 | +100.0% | 0.08% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $3,892,000 | – | 205,000 | +100.0% | 0.07% | – |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $3,468,000 | +178.6% | 315,358 | +100.0% | 0.07% | +4.8% |
| BCLI | Buy | BRAINSTORM CELL THERAPEUTICS | $3,296,000 | +98.6% | 800,000 | +100.0% | 0.06% | -25.0% |
| New | XENON PHARMACEUTICALS INC | $2,972,000 | – | 1,007,706 | +100.0% | 0.06% | – | |
| AFMD | Buy | AFFIMED N V | $3,006,000 | +119.6% | 1,336,428 | +100.0% | 0.06% | -17.4% |
| CSBR | Buy | CHAMPIONS ONCOLOGY INC | $2,836,000 | +200.7% | 773,080 | +110.7% | 0.05% | +14.9% |
| CRIS | Buy | CURIS INC | $2,834,000 | +57.6% | 1,902,402 | +100.0% | 0.05% | -40.0% |
| ZYNE | New | ZYNERBA PHARMACEUTICALS INC | $2,640,000 | – | 261,400 | +100.0% | 0.05% | – |
| OSUR | Buy | ORASURE TECHNOLOGIES INC | $2,462,000 | +160.5% | 109,458 | +100.0% | 0.05% | -2.1% |
| EXEL | Buy | EXELIXIS INC | $2,246,000 | +96.7% | 92,722 | +100.0% | 0.04% | -24.6% |
| FCAU | Buy | FIAT CHRYSLER AUTOMOBILES Nshrs | $2,220,000 | +236.9% | 124,000 | +100.0% | 0.04% | +27.3% |
| LNTH | Buy | LANTHEUS HLDGS INC | $1,914,000 | +101.7% | 107,526 | +100.0% | 0.04% | -22.9% |
| AZRX | Buy | AZURRX BIOPHARMA INC | $1,814,000 | +98.0% | 454,544 | +100.0% | 0.04% | -23.9% |
| CNC | Buy | CENTENE CORP DEL | $1,496,000 | +142.5% | 15,452 | +100.0% | 0.03% | -6.5% |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $1,424,000 | +359.4% | 69,208 | +100.0% | 0.03% | +68.8% |
| PRTO | Buy | PROTEON THERAPEUTICS INC | $1,336,000 | +157.9% | 668,232 | +100.0% | 0.03% | 0.0% |
| RACE | Buy | FERRARI N V | $1,370,000 | +157.0% | 12,400 | +100.0% | 0.03% | -3.7% |
| HSKA | Buy | HESKA CORP | $1,286,000 | +72.6% | 14,600 | +100.0% | 0.02% | -32.4% |
| ALGN | New | ALIGN TECHNOLOGY INC | $1,284,000 | – | 6,896 | +100.0% | 0.02% | – |
| INCY | Buy | INCYTE CORP | $1,312,000 | +85.6% | 11,238 | +100.0% | 0.02% | -30.6% |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $1,298,000 | +119.6% | 72,464 | +100.0% | 0.02% | -16.7% |
| KERX | New | KERYX BIOPHARMACEUTICALS INC | $1,184,000 | – | 166,772 | +100.0% | 0.02% | – |
| BGNE | New | BEIGENE LTDsponsored adr | $1,180,000 | – | 11,400 | +100.0% | 0.02% | – |
| PRAH | New | PRA HEALTH SCIENCES INC | $1,132,000 | – | 14,854 | +100.0% | 0.02% | – |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $1,162,000 | – | 70,212 | +100.0% | 0.02% | – |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $1,080,000 | – | 21,538 | +100.0% | 0.02% | – |
| PRTK | New | PARATEK PHARMACEUTICALS INC | $1,064,000 | – | 42,372 | +100.0% | 0.02% | – |
| IMGN | New | IMMUNOGEN INC | $1,072,000 | – | 140,252 | +100.0% | 0.02% | – |
| INOV | New | INOVALON HLDGS INC | $1,022,000 | – | 60,000 | +100.0% | 0.02% | – |
| TDOC | New | TELADOC INC | $970,000 | – | 29,282 | +100.0% | 0.02% | – |
| CUTR | Buy | CUTERA INC | $990,000 | +219.4% | 23,962 | +100.0% | 0.02% | +18.8% |
| FGEN | New | FIBROGEN INC | $924,000 | – | 17,186 | +100.0% | 0.02% | – |
| AKAOQ | Buy | ACHAOGEN INC | $878,000 | +46.6% | 55,102 | +100.0% | 0.02% | -43.3% |
| ZSAN | Buy | ZOSANO PHARMA INC | $824,000 | +16.9% | 1,000,000 | +100.0% | 0.02% | -54.3% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $850,000 | +92.3% | 15,740 | +100.0% | 0.02% | -27.3% |
| Buy | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $840,000 | +197.9% | 2,000,000 | +100.0% | 0.02% | +14.3% | |
| New | NABRIVA THERAPEUTICS PLC | $862,000 | – | 105,140 | +100.0% | 0.02% | – | |
| MOH | New | MOLINA HEALTHCARE INCcall | $690,000 | – | 100,000 | +100.0% | 0.01% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS INcall | $566,000 | – | 500,000 | +100.0% | 0.01% | – |
| HCM | New | HUTCHISON CHINA MEDITECH LTDsponsored adr | $546,000 | – | 20,000 | +100.0% | 0.01% | – |
| ACST | Buy | ACASTI PHARMA INCcl a new | $534,000 | +116.2% | 373,118 | +100.0% | 0.01% | -16.7% |
| SAGE | Buy | SAGE THERAPEUTICS INCcall | $356,000 | -98.4% | 430,000 | +56.4% | 0.01% | -99.4% |
| SENS | New | SENSEONICS HOLDINGS INC | $320,000 | – | 100,000 | +100.0% | 0.01% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCput | $90,000 | – | 840,000 | +100.0% | 0.00% | – |
| INCY | New | INCYTE CORPcall | $70,000 | – | 200,000 | +100.0% | 0.00% | – |
| IONS | New | IONIS PHARMACEUTICALS INCcall | $48,000 | – | 120,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-05-01 |
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.